Functional compensation may overcome the loss of NOTCH1 in the early stages of cancer initiation and recovery of Notch signaling activity, thus acquiring a potentially oncogenic role that may promote tumor progression, relapse, invasion, tumor cell plasticity, and drug resistance—similar to the situation observed in TNBC. The gene discussed is NOTCH1; the disease is neoplasm.